StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience cash

Cash and short-term investments held at the end of each period.

Dare Bioscience's cash was $12.62M at Jun 30, 2026. For fiscal 2025 it was $24.71M, up 54.5% from the year before. Over ten years it grew 60.4% a year on average. The highest annual figure on record is $51.67M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.71M+54.5%
FY2024Dec 31, 2024$16.00M+48.0%
FY2023Dec 31, 2023$10.81M-68.8%
FY2022Dec 31, 2022$34.67M-32.9%
FY2021Dec 31, 2021$51.67M+1006.6%
FY2020Dec 31, 2020$4.67M-2.3%
FY2019Dec 31, 2019$4.78M-29.8%
FY2018Dec 31, 2018$6.81M-10.0%
FY2017Dec 31, 2017$7.56M+16845.0%
FY2016Dec 31, 2016$44.61K-79.7%
FY2015Dec 31, 2015$219.41K-99.6%
FY2014Dec 31, 2014$51.17M+832.5%
FY2013Dec 31, 2013$5.49M-67.2%
FY2012Dec 31, 2012$16.71M+8.9%
FY2011Dec 31, 2011$15.35M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.62M+150.6%
Q1 FY2026Mar 31, 2026$18.52M+79.3%
Q4 FY2025Dec 31, 2025$24.71M+54.5%
Q3 FY2025Sep 30, 2025$23.08M+105.4%
Q2 FY2025Jun 30, 2025$5.04M-69.3%
Q1 FY2025Mar 31, 2025$10.33M+184.5%
Q4 FY2024Dec 31, 2024$16.00M+48.0%
Q3 FY2024Sep 30, 2024$11.23M-19.2%
Q2 FY2024Jun 30, 2024$16.41M+23.2%
Q1 FY2024Mar 31, 2024$3.63M-81.6%
Q4 FY2023Dec 31, 2023$10.81M-68.8%
Q3 FY2023Sep 30, 2023$13.89M-65.6%
Q2 FY2023Jun 30, 2023$13.33M-58.4%
Q1 FY2023Mar 31, 2023$19.74M-49.8%
Q4 FY2022Dec 31, 2022$34.67M-32.9%
Q3 FY2022Sep 30, 2022$40.39M-11.4%
Q2 FY2022Jun 30, 2022$32.07M+252.0%
Q1 FY2022Mar 31, 2022$39.32M+413.3%
Q4 FY2021Dec 31, 2021$51.67M+1006.6%
Q3 FY2021Sep 30, 2021$45.57M+745.6%
Q2 FY2021Jun 30, 2021$9.11M+70.4%
Q1 FY2021Mar 31, 2021$7.66M+51.8%
Q4 FY2020Dec 31, 2020$4.67M-2.3%
Q3 FY2020Sep 30, 2020$5.39M+121.3%
Q2 FY2020Jun 30, 2020$5.35M-5.0%
Q1 FY2020Mar 31, 2020$5.05M+44.0%
Q4 FY2019Dec 31, 2019$4.78M-29.8%
Q3 FY2019Sep 30, 2019$2.44M-74.5%
Q2 FY2019Jun 30, 2019$5.63M-54.8%
Q1 FY2019Mar 31, 2019$3.51M-77.6%
Q4 FY2018Dec 31, 2018$6.81M-10.0%
Q3 FY2018Sep 30, 2018$9.54M+11.8%
Q2 FY2018Jun 30, 2018$12.45M+31486.2%
Q1 FY2018Mar 31, 2018$15.63M+16519.0%
Q4 FY2017Dec 31, 2017$7.56M+16845.0%
Q3 FY2017Sep 30, 2017$8.53M+60537.1%
Q2 FY2017Jun 30, 2017$39.41K–
Q1 FY2017Mar 31, 2017$94.02K–
Q4 FY2016Dec 31, 2016$44.61K–
Q3 FY2016Sep 30, 2016$14.07K–

More Dare Bioscience figures

See a number that looks wrong?